戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 n information campaign might be an effective countermeasure.
2 V-1 overcame this obstacle by using Vpu as a countermeasure.
3 uture development of a pan-filovirus medical countermeasure.
4 ht therapy and the use of light as a fatigue countermeasure.
5 bility to investigate this virus and develop countermeasures.
6 kers can design and implement more effective countermeasures.
7  of L- and S-tetherins to primate lentiviral countermeasures.
8  of RVF and to use for evaluation of medical countermeasures.
9 remarkable diversity of immune responses and countermeasures.
10 microbial resistance (AMR) demands immediate countermeasures.
11 r ability to study Ebola viruses and develop countermeasures.
12 o better model disease and develop antiviral countermeasures.
13 s animal model for testing candidate medical countermeasures.
14 anding pathogenesis and developing effective countermeasures.
15 ceivers to confound the deception test using countermeasures.
16 ) mice an excellent choice to assess medical countermeasures.
17 eployment of novel and potent anti-infective countermeasures.
18  pathways against which viruses have evolved countermeasures.
19 ion genetics of a drive and proposed genetic countermeasures.
20 nt, production and distribution of effective countermeasures.
21  the pathogenesis of melioidosis and medical countermeasures.
22  immune response to serve as potential viral countermeasures.
23 tion sustains an ongoing quest for effective countermeasures.
24 ther investigation of viral pathogenesis and countermeasures.
25 o increased interest in developing effective countermeasures.
26 sis models for the rapid testing of possible countermeasures.
27 s, highlight the need for effective poxvirus countermeasures.
28  reagents, vaccines, therapeutics, and other countermeasures.
29 ied, precluding the development of effective countermeasures.
30 virions and for developing related antiviral countermeasures.
31  agents could potentially be used as medical countermeasures.
32 ent; and to assess the effectiveness of such countermeasures.
33  free space communications, and illuminators/countermeasures.
34 eed for research aimed at developing medical countermeasures.
35 DA approved pharmaceutical agents or medical countermeasures.
36 logy is desperately needed to develop better countermeasures.
37 of or after treatment with candidate medical countermeasures.
38    Efficacy of drive reversal varies between countermeasures.
39 ers cooperation in the absence of additional countermeasures.
40 virus, underscoring the need for efficacious countermeasures.
41 yelitis for the development of novel medical countermeasures.
42 elopment of effective therapeutics and viral countermeasures.
43 pathology and as a possible target for novel countermeasures.
44 virus transmission is critical to developing countermeasures.
45 tion are needed as early screens for medical countermeasures.
46  for various applications including infrared countermeasures.
47 the ensuing damage by responding with immune countermeasures.
48 dity, and ethics of clinical studies of such countermeasures?
49                  Vaccines are still the best countermeasure against emerging influenza virus infectio
50 ng the potential development of BCX4430 as a countermeasure against human filovirus diseases and othe
51              Although vaccination is a major countermeasure against influenza, current vaccines are n
52 k during non-epidemic periods or as an early countermeasure against nascent outbreaks could therefore
53 sed therapy emerges as an effective and safe countermeasure against OP poisoning.
54 tion of nano-OPH as a catalytic bioscavenger countermeasure against organophosphorus chemical warfare
55  anti-ceramide therapeutics and an effective countermeasure against radiation GI syndrome mortality.
56 e tested the effect of different lights as a countermeasure against sleep-loss decrements in alertnes
57 te that targeting this pathway may provide a countermeasure against the damaging effects of IR exposu
58                          This unique, global countermeasure against the early, IFN-alpha/beta-indepen
59 d the released OPAA may be used as a medical countermeasure against the organophosphorus nerve agents
60 t of lipid-nanoparticle-delivered siRNA as a countermeasure against this highly lethal human disease.
61          Thus, development of more effective countermeasures against acute organophosphorus poisoning
62 nly used to evaluate the efficacy of medical countermeasures against anthrax in support of licensure
63 RP6, identify LRP6 as a potential target for countermeasures against anthrax toxin lethality.
64 evelopment of diagnostic tests and effective countermeasures against C. difficile.
65  aid development and evaluation of effective countermeasures against Ebola.
66 hould not be neglected in the development of countermeasures against ebolaviruses.
67 ironments, which will aid the development of countermeasures against EBOV infection.
68 tagonists may serve as a possible target for countermeasures against HAND.
69 r structure should inform rational design of countermeasures against HCMV, other herpesviruses, and e
70 ntegrates redox signals to regulate specific countermeasures against host defense.
71 ivo conditions indicated that many bacterial countermeasures against host defenses remain critical fo
72 erating the development of effective medical countermeasures against human MHF.
73               Most large DNA viruses exhibit countermeasures against induction of this response.
74                                      Despite countermeasures against influenza virus that prevent (va
75                             Cardioprotective countermeasures against myocardial I-R injury may includ
76 , ciprofloxacin is part of the first-line of countermeasures against numerous high consequence bacter
77 used as a platform for delivering biological countermeasures against pandemic and biological threats.
78   The rapid development of effective medical countermeasures against potential biological threat agen
79                                              Countermeasures against potential biothreat agents remai
80 herapy, as well as more rapid development of countermeasures against potential biothreats.
81         Currently, there are no prophylactic countermeasures against radiation GI syndrome lethality
82 d discuss current efforts to develop medical countermeasures against radiation toxicity.
83 e way for novel therapeutic and prophylactic countermeasures against SSTI.
84  RTA recruited this mechanism to augment its countermeasures against the host antiviral response.
85  opportunities to design appropriate medical countermeasures against them.
86 d is therefore one of the primary targets of countermeasures against these dangerous infectious agent
87 likely to be appropriate for testing medical countermeasures against this EBOV-Makona stock but may p
88                          In order to develop countermeasures against this severe disease, animal mode
89 d to develop and license appropriate medical countermeasures against this virus.
90 eillance mechanism important in host defense countermeasures against virus infection.
91 t adverse effects reveals a viable radiation countermeasures agent.
92        However, for an evaluation of medical countermeasures, AGMs appear to be a more appropriate mo
93         There is one reported pharmaceutical countermeasure and it is vital that this medicine be fur
94 accelerate the development of effective ZIKV countermeasures and increase our preparedness against th
95 such as Pseudomonas syringae, have developed countermeasures and inject virulence proteins into the h
96 point to the need for evaluating therapeutic countermeasures and studying the pathophysiologic effect
97 oneer exciting new breakthroughs in security countermeasures and suicide prevention.
98 that BatA is a target for developing medical countermeasures and that vaccination with a mutant lacki
99                               Development of countermeasures and therapeutics for BoNTs is a priority
100 ent a novel lethal model for studies of CCHF countermeasures, and CCHF-associated CNS disease.
101 to mechanisms of host innate immunity, viral countermeasures, and the evolutionary interplay between
102 ir high mortality rates, the lack of medical countermeasures, and their potential use as instruments
103 ing results, and availability of an approved countermeasure appears to be close.
104                                Optical glare countermeasures are available for daytime driving but no
105 eness of the sperm and the associated female countermeasures are not precisely matched.
106 thogenicity and the development of effective countermeasures are restricted by the current biosafety
107 y in self-correction: Whereas the claim that countermeasures are sufficient is always subject to corr
108                                    Effective countermeasures are urgently needed to prevent and treat
109                                         As a countermeasure, bacterial pathogens have evolved mechani
110 zole aldoximes allows the design of a new OP countermeasure by conversion of hBChE from a stoichiomet
111                                          The countermeasure by influenza B virus is unique in that it
112 l strategy for "non-antibody-based" pathogen countermeasure by targeting the very same "alternative m
113                             The choice among countermeasures by researchers and regulators will depen
114 opriate biomarkers for early diagnosis, thus countermeasure can be taken.
115 of released individuals containing a genetic countermeasure can substantially impact outcomes.
116                     Importantly, therapeutic countermeasures comprising MERS-CoV neutralizing antibod
117 race between prey and predator, measures and countermeasures continuously evolve to increase survival
118   This balance of host response and pathogen countermeasures contributes to chronic infection in high
119 severe hemorrhagic fevers in humans, with no countermeasures currently being available, and must be s
120                                           No countermeasures currently exist for the prevention or tr
121 to evaluate the efficacy of several specific countermeasures developed through years of preclinical w
122 avirus infection and provide new avenues for countermeasure development against pathogenic bunyavirus
123 ging of infectious disease processes may aid countermeasure development and lead to an improved under
124 e to space travel and should be a target for countermeasure development.
125 esponses and protective effects of radiation countermeasure drugs, whereas conventional bone marrow c
126   The development and testing of new medical countermeasures, e.g., vaccines, are thus priorities; ho
127 e antiviral role of ISG15 conjugation and on countermeasures employed by several viruses.
128   An obvious conclusion is that the exercise countermeasures employed were incapable of providing the
129 man Services Public Health Emergency Medical Countermeasures Enterprise.
130 man Services Public Health Emergency Medical Countermeasures Enterprise.
131 dy treatment is currently the only available countermeasure for botulism, a fatal illness caused by f
132 xmedetomidine constitutes a highly effective countermeasure for cocaine's sympathomimetic actions on
133 T1 or STAT2 for proteolytic degradation as a countermeasure for evading IFN responses.
134 on of TRAIL expression could be an effective countermeasure for muXg induced bone loss.
135 ral drugs is also an important public health countermeasure for preventing and treating influenza, th
136 , Uber has been characterized as a potential countermeasure for reducing the estimated 121 million ep
137  across tissues, is emerging as an effective countermeasure for sarcopenia.
138  used prophylactically or therapeutically as countermeasures for a variety of infectious diseases.
139 understanding toxemia and effects of medical countermeasures for anthrax.
140                     HCMV has evolved protean countermeasures for anti-HCMV cellular immunity that fac
141  strategies are being developed as promising countermeasures for influenza virus infections.
142 g the pathogenesis of and evaluating medical countermeasures for persisting Middle East respiratory s
143 dvance the understanding of the use of these countermeasures for post-exposure prophylaxis against Eb
144 elopment and selection of the most effective countermeasures for prophylactic as well as therapeutic
145             We describe the effectiveness of countermeasures for sleepiness, including recent work-ho
146                     In an effort to engineer countermeasures for the category B toxin ricin, we produ
147                                  Nutritional countermeasures for the prevention of poor iron status a
148 st defense and allow us to propose that as a countermeasure, geminivirus proteins reverse TGS by nons
149 gnized, and the need for developing suitable countermeasures has become especially acute following th
150 vailable, progress in preclinical testing of countermeasures has been made.
151   To solve this problem, numerous methods of countermeasure have been proposed.
152                                         As a countermeasure, HIV-1 viral infectivity factor (Vif) bin
153 sed oil and dispersants used as an oil spill countermeasure in the Gulf of Mexico.
154 r speculated attack capabilities can argue a countermeasure in, but no possible observation argues on
155 rt is under way to facilitate the testing of countermeasures in infectious disease emergencies.
156 must suppress or evade an array of host cell countermeasures in order to establish a productive infec
157 virulence factors and targets for developing countermeasures in pathogenic Gram-negative bacteria.
158 celerate the development of specific medical countermeasures in preparation for a future disease outb
159  ecologies of key predators will reveal such countermeasures in prey.
160  developing and testing, in clinical trials, countermeasures in the form of antiviral drugs and vacci
161  and for implementation of effective medical countermeasures, in case a "biological cloud" is seen ov
162                                    Bacterial countermeasures include the up-regulation of copper expo
163 uld render current molecular diagnostics and countermeasures ineffective.
164                                         As a countermeasure, infected cell protein 0 (ICP0) of herpes
165         The animal models used to test these countermeasures involve the deposition of small particle
166 y have unanticipated activities as potential countermeasures is one way to meet this important goal,
167                 To develop effective medical countermeasures, it is important to understand the impor
168 he unusual, anionic dermcidin with effective countermeasures likely contributes to the extraordinary
169                                         As a countermeasure, many viruses have evolved viral RNA sile
170                     Licensure of any medical countermeasure may require demonstration of efficacy in
171 demonstrate that promising candidate medical countermeasures may not completely clear EBOV infection.
172 are sometimes harmful to females, and female countermeasures may thwart the interests of males, which
173                 To date, no approved medical countermeasures (MCM) are available to combat MERS-CoV i
174  present there are no Ebola-specific medical countermeasures (MCMs) with proven effectiveness.
175                                         As a countermeasure, members of the genus Begomovirus (e.g.,
176                                         As a countermeasure, numerous phages are known that produce p
177 into the role of cellular miRNAs in possible countermeasures of HCV for suppression of the host antiv
178 igated the tetherin sensitivity and possible countermeasures of herpes simplex virus 1 (HSV-1).
179 ame sensitivity to nondegradative lentiviral countermeasures of HIV-2 and SIVmac, respectively.
180 olved to replicate and to overcome antiviral countermeasures of the infected cell.
181                 To gain insights on possible countermeasures of virus for the suppression of host ant
182 a broad antiviral strategy to antagonize the countermeasures of viruses and bypass the dsRNA-induced
183  although this can be disabled by parasitoid countermeasures (parasitoid virulence).
184  Whether host autophagic responses and viral countermeasures play similar roles in plant-virus intera
185                  Although in-flight exercise countermeasures probably reduced the effects of microgra
186             Expression of presumptive viral "countermeasure" proteins that are known to inhibit Daxx
187 overy posts a challenge to develop effective countermeasures, provides a novel tool for studying intr
188                    A systematic search for a countermeasure relies on a good understanding of the mec
189           Development of appropriate medical countermeasures requires a thorough understanding of the
190 at began in late 2013, the lack of effective countermeasures resulted in chains of serial infection a
191                        The lack of efficient countermeasure strategies, the potential for dispersion
192  decoding validity may be the deployment of "countermeasures": strategies used to mask memory signals
193 binding to the host receptor is an efficient countermeasure strategy.
194 e addressed by efficient, quickly deployable countermeasures such as antidotes reactivating acetylcho
195                     Development of effective countermeasures, such as therapeutics and an effective v
196 Here we show that unlike other virus-encoded countermeasures, such as those from primate viruses rela
197 h on injury control; to design and implement countermeasures that address injury risk factors and def
198 ductive virus infection often requires viral countermeasures that block innate immunity.
199                                              Countermeasures that lessen the effects of unloading inc
200 LPS sensing mechanisms and discuss bacterial countermeasures that promote infection.
201 employ to prevent rotavirus invasion and the countermeasures that these viruses have successfully dev
202                         To develop effective countermeasures, the basis of this atrophy needs to be b
203 fection are useful for screening prospective countermeasures, they are frequently not useful for pred
204  findings identify AFSC transplantation as a countermeasure to bone fragility.
205  in recent years as a potential prophylactic countermeasure to decrease the prevalence of hospital-ac
206 by a parasite and represents a new potential countermeasure to evade the generation of a correct immu
207  the final stage of pursuit, presumably as a countermeasure to keep evading moths within their "acous
208 e that the ICP0-PML.I interaction reflects a countermeasure to PML-related antiviral restriction.
209  infected cells has been proposed as a viral countermeasure to potential host cell RNA interference-b
210  other industries, but the use of a nap as a countermeasure to prevent fatigue in residents is uncert
211 equate protein is consumed at each meal as a countermeasure to sarcopenia are presented and discussed
212 o a mitochondrial toxin, revealing bacterial countermeasures to animal defence.
213 n the treatment of disease but also serve as countermeasures to biological warfare.
214                         Mammals have evolved countermeasures to block siderophore-mediated iron acqui
215 eakness is essential to developing effective countermeasures to combat this important problem.
216 based design and optimization of therapeutic countermeasures to combat this potential agent of bioter
217 mmune responses, viruses have also developed countermeasures to defeat dsRNA-induced antiviral strate
218                                    Fungi use countermeasures to detoxify plant antimicrobial compound
219 ggest that GraS mediates specific resistance countermeasures to HDPs in immune contexts that are high
220                                         Tick countermeasures to host defenses reduce T-lymphocyte pro
221               The Herpesviridae have evolved countermeasures to IFN responses.
222                    Many viruses have evolved countermeasures to inhibit the IFN pathway, thereby subv
223 , if any, dsRNA or that more efficient viral countermeasures to mask dsRNA are mounted.
224  viral replication, and viruses have evolved countermeasures to neutralize them.
225                                  In crafting countermeasures to offset this, it is important to know
226 ve care unit-associated weakness and develop countermeasures to preserve muscle function, lessen illn
227   Based on the proposed reaction mechanisms, countermeasures to prevent Cr oxidation (addition of NH4
228 us to pinpoint a possible source and to take countermeasures to prevent further spread of the epidemi
229 ecovery in space flight, as well as possible countermeasures to prevent immunosuppression or enhance
230 tion and for the initial phase of developing countermeasures to prevent or treat viral infections.
231 hasise the need for development of effective countermeasures to promote sleep.
232 tes has increased efforts to develop medical countermeasures to protect against radiation toxicities
233                                    Immediate countermeasures to reduce the dangers of air bags to chi
234                Thus, it is desirable to have countermeasures to reverse a drive if a problem arises.
235  hosts have developed a variety of metabolic countermeasures to sense and resist these viral changes.
236 t, underscoring the importance of developing countermeasures to SIV that are effective before infecti
237                      Behavioural 'autogenic' countermeasures to the development of sickness, such as
238 ron-mediated antiviral defenses and by viral countermeasures to these defenses.
239        Adaptation remains the most effective countermeasure together with established medications, no
240 being essential for controlling host defense countermeasures triggered by microbial cytosolic DNA and
241  be used in a potential bioterrorist attack, countermeasures urgently are needed to counteract the pa
242        To gain insights about possible viral countermeasures used by this virus to suppress the host
243 nerability of fMRI-based memory detection to countermeasures, using a paradigm that bears resemblance
244  continued investments in the development of countermeasures (vaccines, therapeutic agents, and diagn
245     Without the transmembrane potential as a countermeasure, water will readily flow inside the highe
246         In an attempt to develop HPS medical countermeasures, we constructed an expression plasmid, p
247 ens and for initiating cellular host defence countermeasures, which include the production of type I
248 l concern for space travelers, and a dietary countermeasure would be of great benefit.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top